Legis Daily

A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.

USA115th CongressS-892| Senate 
| Updated: 4/7/2017
Kirsten E. Gillibrand

Kirsten E. Gillibrand

Democratic Senator

New York

Cosponsors (2)
John McCain (Republican)Joe Manchin (Independent)

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 7, 2017
Introduced in Senate
Apr 7, 2017
Read twice and referred to the Committee on the Judiciary.
Dec 13, 2017

Latest Companion Bill Action

HR 115-4408
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • April 7, 2017
    Introduced in Senate


  • April 7, 2017
    Read twice and referred to the Committee on the Judiciary.


  • December 13, 2017

    Latest Companion Bill Action

    HR 115-4408
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Law Enforcement

Related Bills

  • HR 115-4482: To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.
  • HR 115-4408: To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
  • HR 115-3964: To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsPrescription drugs

A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.

USA115th CongressS-892| Senate 
| Updated: 4/7/2017
Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 7, 2017
Introduced in Senate
Apr 7, 2017
Read twice and referred to the Committee on the Judiciary.
Dec 13, 2017

Latest Companion Bill Action

HR 115-4408
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • April 7, 2017
    Introduced in Senate


  • April 7, 2017
    Read twice and referred to the Committee on the Judiciary.


  • December 13, 2017

    Latest Companion Bill Action

    HR 115-4408
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Kirsten E. Gillibrand

Kirsten E. Gillibrand

Democratic Senator

New York

Cosponsors (2)
John McCain (Republican)Joe Manchin (Independent)

Judiciary Committee

Crime and Law Enforcement

Related Bills

  • HR 115-4482: To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.
  • HR 115-4408: To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
  • HR 115-3964: To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsPrescription drugs